Odyssey Health, Inc. (ODYY)

Odyssey Health Income Statement

Financials in millions USD. Fiscal year is August - July.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2024	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020
Selling, General & Admin	1.53	1.51	2.12	2.92	4.79	3.85
Research & Development	0.03	0.06	0.2	1.32	1.63	-
Operating Expenses	1.87	2.14	5.14	8.11	6.42	3.85
Operating Income	-1.87	-2.14	-5.14	-8.11	-6.42	-3.85
Interest Expense	-0.4	-0.52	-0.61	-0.84	-1.07	-0.5
Other Non Operating Income (Expenses)	0.01	0.01	0.01	0.5	-	-
EBT Excluding Unusual Items	-2.26	-2.65	-5.75	-8.44	-7.49	-4.35
Gain (Loss) on Sale of Investments	-14.96	-14.59	-	-	-	-
Gain (Loss) on Sale of Assets	15.9	16.4	-	-	-	-
Other Unusual Items	-	-	-	-	0.05	-
Pretax Income	-1.32	-0.84	-5.92	-8.44	-16.88	-4.35
Net Income	-1.32	-0.84	-5.92	-8.44	-16.88	-4.35
Preferred Dividends & Other Adjustments	0.06	0.06	-	-	-	-
Net Income to Common	-1.39	-0.91	-5.92	-8.44	-16.88	-4.35
Shares Outstanding (Basic)	103	97	83	89	94	87
Shares Outstanding (Diluted)	103	97	83	89	94	87
Shares Change (YoY)	24.53%	17.40%	-7.10%	-5.06%	7.59%	24.64%
EPS (Basic)	-0.01	-0.01	-0.07	-0.09	-0.18	-0.05
EPS (Diluted)	-0.01	-0.01	-0.07	-0.09	-0.18	-0.05
Free Cash Flow	-1.4	-1.22	-1.47	-3.18	-3.42	-0.65
Free Cash Flow Per Share	-0.01	-0.01	-0.02	-0.04	-0.04	-0.01
EBITDA	-1.87	-2.14	-5.14	-8.1	-6.42	-3.84
D&A For EBITDA	0	0	0	0	0.01	0.01
EBIT	-1.87	-2.14	-5.14	-8.11	-6.42	-3.85

Source: S&P Capital IQ. Standard template. Financial Sources.